In this paper, some of the work by Talbott has been repeated and other reactions of 4-picoline and pyridine N-oxides with aromatic halogen compounds have been investigated.

No description available.

The study herein described involved the detection of pyridine N-oxide reductase activity in cell-free extracts of E. coli 9723, the determination of co-factors necessary for the enzymatic process, a study of the optimum conditions for enzyme catalysis, and a general characterization of the enzyme.

This dissertation looked at the crystal structure analysis of 2-hydroxymethylpyridine-N-oxide sine this compound could provide data on both substituent effects and hydrogen bonding.

Detailed mechanistic studies on the palladium-catalyzed direct arylation of pyridine N-oxides are presented. The order of each reaction component is determined to provide a general mechanistic picture. The C-H bond cleaving step is examined in further detail through computational studies, and the calculated results are in support of an inner-sphere concerted metallation-deprotonation (CMD) pathway. Competition experiments were conducted using N-oxides of varying electronic characters, and results revealed an enhancement of rate when using a more electron-deficient species which is in support of a CMD transition state. The effect of base on reaction rate was also examined and it was found that a carboxylate base was required for the reaction to proceed. This led to the conclusion that Pd(OAc)2 plays a pivotal role in the reaction mechanism as more than merely a pre-catalyst, but as a source of acetate base required for the C-H bond cleavage step.

Detailed mechanistic studies on the palladium-catalyzed direct arylation of pyridine N-oxides are presented. The order of each reaction component is determined to provide a general mechanistic picture. The C-H bond cleaving step is examined in further detail through computational studies, and the calculated results are in support of an inner-sphere concerted metallation-deprotonation (CMD) pathway. Competition experiments were conducted using N-oxides of varying electronic characters, and results revealed an enhancement of rate when using a more electron-deficient species which is in support of a CMD transition state. The effect of base on reaction rate was also examined and it was found that a carboxylate base was required for the reaction to proceed. This led to the conclusion that Pd(OAc)2 plays a pivotal role in the reaction mechanism as more than merely a pre-catalyst, but as a source of acetate base required for the C-H bond cleavage step.

Detailed mechanistic studies on the palladium-catalyzed direct arylation of pyridine N-oxides are presented. The order of each reaction component is determined to provide a general mechanistic picture. The C-H bond cleaving step is examined in further detail through computational studies, and the calculated results are in support of an inner-sphere concerted metallation-deprotonation (CMD) pathway. Competition experiments were conducted using N-oxides of varying electronic characters, and results revealed an enhancement of rate when using a more electron-deficient species which is in support of a CMD transition state. The effect of base on reaction rate was also examined and it was found that a carboxylate base was required for the reaction to proceed. This led to the conclusion that Pd(OAc)2 plays a pivotal role in the reaction mechanism as more than merely a pre-catalyst, but as a source of acetate base required for the C-H bond cleavage step.

Detailed mechanistic studies on the palladium-catalyzed direct arylation of pyridine N-oxides are presented. The order of each reaction component is determined to provide a general mechanistic picture. The C-H bond cleaving step is examined in further detail through computational studies, and the calculated results are in support of an inner-sphere concerted metallation-deprotonation (CMD) pathway. Competition experiments were conducted using N-oxides of varying electronic characters, and results revealed an enhancement of rate when using a more electron-deficient species which is in support of a CMD transition state. The effect of base on reaction rate was also examined and it was found that a carboxylate base was required for the reaction to proceed. This led to the conclusion that Pd(OAc)2 plays a pivotal role in the reaction mechanism as more than merely a pre-catalyst, but as a source of acetate base required for the C-H bond cleavage step.

This thesis describes the development of new synthetic methodologies for preparation of bioactive interesting compounds, e.g. substituted pyridines, piperidines or piparazines. Thesecompounds are synthesized from commercially available, cheap and easily prepared reagents, videlicet the reaction between Grignard reagents and heterocyclic N-oxides.  The first part of this thesis deals with an improvement for synthesis of dienal-oximes and substituted pyridines. This was accomplished by a rapid addition of Grignard reagents to pyridine N-oxides at rt. yielding a diverse set of substituted dienal-oximes. During these studies, it was observed that the obtained dienal-oxmies are prone to ring-close upon heating. By taking advantage of this, a practical synthesis of substituted pyridines was developed. In the second part, an ortho-metalation of pyridine N-oxides using Grignard reagents is discussed. The method can be used for incorporation of a range of different electrophiles, including aldehydes, ketones and halogens. Furthermore, the importance for incorporation of halogens are exemplified through a Suzuki–Miyaura coupling reaction of 2-iodo pyridine N-oxides and different boronic acids. Later it was discovered that if the reaction temperature is kept below -20 °C, the undesired ringopening can be avoided. Thus, the synthesis of 2,3-dihydropyridine N-oxide, by reacting Grignard reagents with pyridine N-oxides at -40 °C followed by sequential addition of aldehyde or ketone, was accomplished. The reaction provides complete regio- and stereoselectivity yielding trans-2,3-dihydropyridine N-oxides in good yields. These intermediate products could then be used for synthesis of either substituted piperidines, by reduction, or reacted in a Diels–Alder cycloaddtion to give the aza-bicyclo compound. In the last part of this thesis, the discovered reactivity for pyridine N-oxides, is applied on pyrazine N-oxides in effort to synthesize substituted piperazines. These substances are obtained by the reaction of Grignard reagents and pyrazine N-oxides at -78 °C followed by reduction and protection, using a one-pot procedure. The product, a protected piperazine, that easily can be orthogonally deprotected, allowing synthetic modifications at either nitrogens in a fast and step efficient manner. Finally, an enantioselective procedure using a combination of PhMgCl and (-)-sparteine is discussed, giving opportunity for a stereoselective synthesis of substituted piperazines.

Notre travail a démontré l’implication du p-crésyl sulfate (PCS), de la zinc a2glycoprotéine (ZAG) et du triméthylamine-N-oxide (TMAO), représentants des 3 groupes de toxines urémiques décrits par le groupe EUTox, dans la survenue des complications métaboliques de la maladie rénale chronique (MRC). Nous avons démontré que l’augmentation du PCS induisait une insulino-résistance, une perte de masse grasse et une redistribution des lipides chez la souris, en montrant une altération de la voie de signalisation de l’insuline dans le muscle strié squelettique. Nous avons ensuite montré que la protéine ZAG était surexprimée par le tissu adipeux dans la MRC. Du fait de ses effets lipolytiques et anti-lipogeniques, l’élévation des concentrations tissulaires de cette adipokine pourrait être impliquée dans les phénomènes de dyslipidémies et dysfonction adipocytaire observés dans la MRC. Chez l’homme, notre étude a confirmé l’augmentation des concentrations de ZAG dans les stades 5 et 5D de la MRC uniquement, faiblement corrélée au débit de filtration glomérulaire (DFG). L’étude n’a en revanche pas permis de mettre en évidence de corrélation entre les taux circulants de ZAG et les critères de complications métaboliques, notamment la dénutrition. Enfin, en l’absence de données précises sur l’élimination rénale du TMAO et la physiopathologie de son augmentation dans la MRC, nous avons conduit une étude clinique mettant en évidence une forte corrélation entre les taux de TMAO et le DFG mesuré, excluant une contribution tubulaire à son excrétion. Les résultats d’une étude préliminaire chez l’animal suggèrent une possible implication du TMAO dans le développement de la fibrose rénale / Our work demonstrated the role of p-cresyl sulfate (PCS), zinc a2-glycoprotein (ZAG) and trimethylamine-N-oxide (TMAO) that belong to the 3 groups of uremic toxins described by the EUTox group, in the metabolic complications of chronic kidney disease (CKD). We demonstrated that the increase of PCS induced an insulin resistance, a loss of fat mass and a lipid redistribution in mice, showing an alteration of the insulin pathway in skeletal muscle. We showed a surexpression of ZAG by adipose tissue in CKD. Because of ZAG lipolytic and anti-lipogenic effects, the elevation of its tissu levels could be implicated in dyslipidemia and adipose dysfonction in CKD. In humans, our study confirmed the elevation of ZAG concentrations only in CKD stages 5 and 5D, with a poor correlation with the glomerular filtration rate (GFR). The study did not shown correlation between ZAG circulating levels and metabolic complications, as wasting. With the lack of data about renal elimination and physiopathology of TMAO, we conducted a clinical study that reported a strong correlation between TMAO levels and measured GFR, without proof of tubular excretion of TMAO. Results of a preliminary animal study suggests a possible implication of TMAO in the renal fibrosis